Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NatureCeuticals Blood Cleanser is a capsule-based dietary supplement containing 308 mg of Orthosiphon stamineus leaf extract per capsule. The product is marketed as a "blood cleanser" and is designed to promote blood cleansing, with recommended uses including support for acute and chronic gout, cholesterol reduction, and vasodilation. It is listed as a complementary medicine with the Australian Therapeutic Goods Administration (TGA). Orthosiphon stamineus, also known as Java tea or cat's whiskers, has been traditionally used for its purported anti-inflammatory and diuretic properties; however, robust clinical evidence supporting these specific health claims remains limited[1]. The mechanism of action is not well defined but may involve modulation of inflammatory pathways or antioxidant effects attributed to compounds such as rosmarinic acid found in the plant extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NatureCeuticals Blood Cleanser.